You are cordially invited to join the Sidley Breakfast Discussion with innovative biotech companies and investors from China and the U.S.!
A team of our seasoned life sciences partners, along with guest speakers from Morgan Stanley, will share with you their insights on various issues, including:
- Big Data & Fast CPUs: Corporate Strategies for AI-Driven Drug Discovery
- Stick Without Carrot? US Capital Market Access Restrictions to Chinese Companies
- Key Legal Matters Which You Should Pay Attention to for a HK IPO
- Executing a Successful Biotech IPO
Speakers:
Meng Ding, Partner, Sidley
Tom Duley, Partner, Sidley
Ruchun Ji, Partner, Sidley
Mengyu Lu, Partner, Sidley
Andy Wu, Managing Director, Head of Asia Pacific Healthcare IBD, Morgan Stanley
Cathy Zhang, Managing Director, Asia Pacific Global Capital Markets, Morgan Stanley
Kenneth Sun, Executive Director, Asia Pacific Healthcare IBD, Morgan Stanley
Space is limited. Please RSVP no later than January 5, 2020.
For questions, please contact sfevents@sidley.com.
